With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
The unprecedented cost of CAR-T cells, which is likely the tip of the iceberg of future policy challenges regarding where to draw the line on the price of a human life, all without discouraging further awe-inspiring medical breakthroughs. | Jacobson, JAMA 2019